Sepsis is believed to be one of the most life-threatening medical conditions. This condition is associated with an infection that triggers inflammation responses leading to inflammations in different body parts and organs. In most cases, bacterial infections serve as the causes of sepsis. In practice, sepsis can be viewed as a condition that occur in three stages with sepsis progressing into severe sepsis and then septic shock that is characterized by organ failure. Evidence indicates that incidences for severe sepsis and septic shock have increased rapidly in the past decade and this is attributable to the increase of the aging population. As a result, severe sepsis and septic shock are considered some of the most causes of mortality and morbidity in intensive care. This phenomenon has prompted physicians and professional societies to implement management procedures that focus on early intervention. Therefore, this presentation will provide a comprehensive discussion on pharmacological and non pharmacological treatment of sepsis.
Table of Contents
1. INTRODUCTION
1.1 Prognosis of Sepsis
2. PHARMACOLOGICAL AND NON PHARMACOLOGICAL TREATMENT OF SEPSIS
2.1 EARLY MANAGEMENT
2.1.1 Respiration Support
2.1.2 Assessment of Perfusion
2.1.3 Establishment of Venous Access
2.1.4 Urinary Catheterization
2.1.5 Fluid Resuscitation
2.1.6 Vasopressor Therapy
2.1.7 Inotropic Therapy
2.1.8 Red Blood Cell Transfusions
2.2 CONTROL OF THE SEPTIC FOCUS
2.2.1 Identification of the Septic Focus (Diagnosis)
2.2.2 Antimicrobial Therapy
2.3 ADDITIONAL THERAPIES
2.3.1 Corticosteroid Therapy
2.3.2 Intensive Insulin Therapy
2.3.3 Surgical Treatment
3. CONCLUSION
Objectives and Topics
This work provides a comprehensive clinical overview of sepsis management, focusing on early intervention strategies to mitigate the high mortality risks associated with severe sepsis and septic shock. It evaluates current pharmacological and non-pharmacological protocols used to stabilize patients and eradicate infection.
- International guidelines for sepsis management
- Physiological targets for early goal-directed therapy
- Pharmacological interventions including vasopressors and antimicrobials
- Diagnostic procedures for identifying the septic focus
- Supportive care measures such as fluid resuscitation and respiratory support
Excerpt from the Book
Early goal-directed therapy (EGDT)
Early goal-directed therapy (EGDT): this therapy involves the administration of intravenous fluid following physiologic targets. It is done within the first 6 hours of sepsis presentation. EGDT seems to have gained an unprecedented acceptance in clinical practice. The main physiologic targets include MAP (mean arterial pressure) of ≥65 mmHg, CVP (central venous pressure) of 8 to 12 mmHg, urine output of ≥0.5 mL/kg/hr, and oxyhemoglobin saturation in central venous (ScvO2) of more than 70% (Schmidt & Mandel, 2015).
Summary of Chapters
INTRODUCTION: Provides an overview of sepsis as a life-threatening condition and defines the scope of management guidelines and nursing care objectives.
PHARMACOLOGICAL AND NON PHARMACOLOGICAL TREATMENT OF SEPSIS: Details the primary clinical interventions for sepsis, categorized into early management, infection source control, and additional therapeutic supportive measures.
CONCLUSION: Summarizes the necessity of rapid response in eradicating infection and maintaining organ function to reduce patient morbidity and mortality.
Keywords
Sepsis, Septic Shock, Early Goal-Directed Therapy, Vasopressor Therapy, Antimicrobial Therapy, Fluid Resuscitation, Organ Failure, Perfusion, SIRS, Intensive Care, Corticosteroids, Glycemic Control, Mortality, Nursing Care, Evidence-Based Practice.
Frequently Asked Questions
What is the primary focus of this work?
The work focuses on the clinical management of sepsis, specifically addressing the life-threatening progression into severe sepsis and septic shock, and the necessary early interventions.
What are the central themes of the document?
The central themes include early hemodynamic stabilization, pharmacological treatments, identification of the infection site, and maintaining adequate organ function.
What is the primary goal of the presented sepsis guidelines?
The primary goal is to provide a comprehensive discussion on international management standards to enable healthcare providers to perform evidence-based and patient-centered care.
Which scientific methodology is the basis of this work?
The work is based on a synthesis of existing international medical guidelines and clinical evidence regarding the treatment of sepsis and septic shock.
What topics are covered in the main section?
The main section covers early management (respiration, perfusion, fluid resuscitation, vasopressors), source control (diagnosis, antimicrobials), and additional therapies (corticosteroids, insulin, surgery).
Which keywords best characterize this document?
Key terms include Sepsis management, EGDT, Fluid resuscitation, Vasopressor therapy, and Antimicrobial treatment.
What is the clinical significance of the MEDS score?
The MEDS (Mortality in Emergency Department Sepsis) score is utilized as a tool to evaluate the severity of sepsis in patients presenting at the emergency department.
Why is fluid resuscitation considered critical in sepsis management?
Fluid resuscitation is essential to restore perfusion and correct the intravascular hypovolemia that typically accompanies severe sepsis and septic shock.
How is glycemic control addressed in the treatment plan?
Intensive insulin therapy is recommended to manage insulin resistance and hyperglycemia, with the target of maintaining glucose levels below 180 mg/dL.
What defines the early management phase regarding respiratory support?
Early management involves stabilizing respiration through supplemental oxygen or mechanical ventilation for patients suffering from dyspnea or inadequate perfusion.
- Citar trabajo
- Patrick Kimuyu (Autor), 2018, Sepsis Management. How to treat Sepsis in pharmacological and non-pharmacological ways, Múnich, GRIN Verlag, https://www.grin.com/document/388557
